Follow-up of an Asymptomatic Chagas Disease Population of Children after Treatment with Nifurtimox (Lampit) in a Sylvatic Endemic Transmission Area of Colombia

PLoS Neglected Tropical Diseases

Volumn 9, Issue 2, 2015, Pages

  Bianchi, Fiorella ^a   Cucunubá, Zulma ^b   Guhl, Felipe ^a   González, Nadia Lorena ^a   Freilij, Hector ^c   Nicholls, Rubén Santiago ^b   Ramírez, Juan David ^a   Montilla, Marleny ^b   Flórez, Astrid Carolina ^b   Rosas, Fernando ^d   Saavedra, Victor ^e   Silva, Nubia ^f  

^a UNIVERSIDAD DE LOS ANDES   (Colombia)

^b INSTITUTO NACIONAL DE SALUD   (Colombia)

^c Programa Nacional de Control de Chagas   (Argentina)

^d Division of Cardiovascular Surgery   (Colombia)

^e Centro de Salud   (Colombia)

^f Servinsalud Ltda   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

NIFURTIMOX; ANTITRYPANOSOMAL AGENT; PROTOZOAL DNA;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CHAGAS DISEASE; CHILD; COLOMBIA; DIARRHEA; DISEASE TRANSMISSION; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; HEADACHE; HEART MUSCLE NECROSIS; HEMAGGLUTINATION; HUMAN; INSOMNIA; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; PETECHIA; PRESCHOOL CHILD; PRURITUS; RASH; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SCREENING TEST; SORE THROAT; TRYPANOSOMA CRUZI; VOMITING; ASYMPTOMATIC DISEASE; BLOOD; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; PARASITOLOGY;

ADOLESCENT; ADULT; ASYMPTOMATIC DISEASES; CHAGAS DISEASE; CHILD; CHILD, PRESCHOOL; COLOMBIA; DNA, PROTOZOAN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NIFURTIMOX; REAL-TIME POLYMERASE CHAIN REACTION; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

EID: 84924031840     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003465     Document Type: Article

References (47)

1. WHO Expert Committee (2002) Control of Chagas disease. World Health Organ Tech Rep Ser 905: i–vi, 1–109, back cover. 12092045
2. Rassi A, Rassi A, Marcondes de Rezende J, (2012) American trypanosomiasis (Chagas disease). Infect Dis Clin North Am 26: 275–291. doi: 10.1016/j.idc.2012.03.002 22632639
3. OPS (2006) Estimación cuantitativa de la enfermedad de Chagas en las Américas. Available: http://www.bvsops.org.uy/pdf/chagas19.pdfhttp://www.bvsops.org.uy/pdf/chagas19.pdf.
4. Moncayo A, Silveira AC, (2009) Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz 104 Suppl 1: 17–30. 19753454
5. Zingales B, Miles MA, Campbell DA, Tibayrenc M, Macedo AM, et al. (2012) The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis 12: 240–253.
6. Rassi A, Rassi A, Marin-Neto JA, (2010) Chagas disease. Lancet 375: 1388–1402. doi: 10.1016/S0140-6736(10)60061-X 20399979
7. Guhl F, Nicholls R, Montoya R, Rosas F, Velasco VM, et al. (2004) Rapid negativization of serology after treatment with benznidazole for chagas disease in a group of colombian schoolchildren. Medimond International Proceedings. Spain, Vol. 1. pp. 107–114. 17271616
8. Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, et al. (1998) Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas’ disease. Am J Trop Med Hyg 59: 526–529. 9790423
9. Andrade ALSS, Martelli CMT, Oliveira RM, Silva SA, Aires AIS, et al. (2004) Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am J Trop Med Hyg 71: 594–597. 15569790
10. Rodriques Coura J, de Castro SL, (2002) A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3–24. 11992141
11. Jannin J, Villa L, (2007) An overview of Chagas disease treatment. Mem Inst Oswaldo Cruz 102 Suppl 1: 95–97. 17906803
12. Fabbro DL, Streiger ML, Arias ED, Bizai ML, del Barco M, et al. (2007) Trypanocide treatment among adults with chronic Chagas disease living in Santa Fe city (Argentina), over a mean follow-up of 21 years: parasitological, serological and clinical evolution. Rev Soc Bras Med Trop 40: 1–10. 17665535
13. Rassi A, Luquetti AO, Rassi A, Rassi GG, Rassi SG, et al. (2007) Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease. Am J Trop Med Hyg 76: 58–61. 17255230
14. Villar JC, Perez JE, Cortés OL, Riarte A, Pepper ML, et al. (2012) Trypanocidal agents for chronic asymptomatic T. cruzi infections. An Updated systematic review and meta-analysis. Rio de Janeiro: Memories XVIII International Congress for Tropical Medicine and Malaria. p. 561.
15. Villar JC, Martínez L, Herrera V, Cárdenas M, Ferreira S, et al. (2012) Effects of a combined treatment with Itraconazole/Pravastatin and Allendronate for asymptomatic T. cruzi-infected individuals: A randomized controlled trial in the CHICAMOCHA Study Rio de Janeiro: Memories XVIII International Congress for Tropical Medicine and Malaria. p. 561.
16. Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, et al. (2014) Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease. N Engl J Med 370: 1899–1908. doi: 10.1056/NEJMoa1313122 24827034
17. Ribeiro I, Sevcsik A-M, Alves F, Diap G, Don R, et al. (2009) New, improved treatments for Chagas disease: from the R&D pipeline to the patients. PLoS Negl Trop Dis 3: e484. doi: 10.1371/journal.pntd.0000484 19582163
18. Urbina JA, Docampo R, (2003) Specific chemotherapy of Chagas disease: controversies and advances. TRENDS in Parasitology. Vol.19 No.11: 495. 14580960
19. OPS/OMS (1998) Tratamiento etiológico de la enfermedad de Chagas. Conclusiones de una consulta técnica. Rio de Janeiro, Brasil. Available: http://cidbimena.desastres.doihn/filemgmt/files/tratamientochagas.pdf.
20. Ferreira AW, Belem ZR, Lemos EA, Reed SG, Campos-Neto A, (2001) Enzyme-linked immunosorbent assay for serological diagnosis of Chagas’ disease employing a Trypanosoma cruzi recombinant antigen that consists of four different peptides. J Clin Microbiol 39: 4390–4395. 11724850
21. Lopez C, Duque S, Orozco LC, Camargo D, Gualdron L, et al. (1999) Inmunodiagnóstico de la infección chagásica por ELISA. Bioméd Rev Inst Nac Salud 19: 159–163.
22. Camargo ME, (1966) Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop São Paulo 8: 227–235.
23. Duque S, Pelaez D, Corredor A, (1993) Cultivo in vitro de parásitos de la familia Trypanosomatidae. Manual de Procedimientos. Bogota, Colombia. pp. 41–43.
24. Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, et al. (2009) Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in chagas disease patients. PLoS Negl Trop Dis 3: e419. doi: 10.1371/journal.pntd.0000419 19381287
25. Ramírez JD, Montilla M, Cucunubá ZM, Floréz AC, Zambrano P, et al. (2013) Molecular epidemiology of human oral Chagas disease outbreaks in Colombia. PLoS Negl Trop Dis 7: e2041. doi: 10.1371/journal.pntd.0002041 23437405
26. Burgos JM, Diez M, Vigliano C, Bisio M, Risso M, et al. (2010) Molecular identification of Trypanosoma cruzi discrete typing units in end-stage chronic Chagas heart disease and reactivation after heart transplantation. Clin Infect Dis Off Publ Infect Dis Soc Am 51: 485–495.
27. De Andrade AL, Zicker F, Rassi A, Rassi AG, Oliveira RM, et al. (1998) Early electrocardiographic abnormalities in Trypanosoma cruzi-seropositive children. Am J Trop Med Hyg 59: 530–534. 9790424
28. Ribeiro AL, Sabino EC, Marcolino MS, Salemi VMC, Ianni BM, et al. (2013) Electrocardiographic abnormalities in Trypanosoma cruzi seropositive and seronegative former blood donors. PLoS Negl Trop Dis 7: e2078. doi: 10.1371/journal.pntd.0002078 23469305
29. Salazar-Schettino PM, Perera R, Ruiz-Hernandez AL, Bucio Torres MI, Zamora-Gonzalez C, et al. (2009) Chagas disease as a cause of symptomatic chronic myocardopathy in Mexican children. Pediatr Infect Dis J 28: 1011–1013. doi: 10.1097/INF.0b013e3181ad8425 19859016
30. Britto CC, (2009) Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. Mem Inst Oswaldo Cruz 104 Suppl 1: 122–135. 19753467
31. Bertocchi GL, Vigliano CA, Lococo BG, Petti MA, Viotti RJ, (2013) Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria. Trans R Soc Trop Med Hyg 107: 372–376. doi: 10.1093/trstmh/trt029 23612468
32. Viotti R, Vigliano C, Alvarez MG, Lococo B, Petti M, et al. (2011) Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease. PLoS Negl Trop Dis 5: e1314. doi: 10.1371/journal.pntd.0001314 21909451
33. Pinto AY das N, Valente V da C, Coura JR, Valente SA da S, Junqueira ACV, et al. (2013) Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease. PloS One 8: e64450. doi: 10.1371/journal.pone.0064450 23724050
34. Solari A, Ortíz S, Soto A, Arancibia C, Campillay R, et al. (2001) Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. J Antimicrob Chemother 48: 515–519. 11581230
35. Schijman AG, Altcheh J, Burgos JM, Biancardi M, Bisio M, et al. (2003) Aetiological treatment of congenital Chagas’ disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother 52: 441–449. 12917253
36. Sánchez G, Coronado X, Zulantay I, Apt W, Gajardo M, et al. (2005) Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis. Parasite Paris Fr 12: 353–357. 16402568
37. Piron M, Fisa R, Casamitjana N, López-Chejade P, Puig L, et al. (2007) Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195–200. 17662227
38. Duffy T, Cura CI, Ramirez JC, Abate T, Cayo NM, et al. (2013) Analytical performance of a multiplex Real-Time PCR assay using TaqMan probes for quantification of Trypanosoma cruzi satellite DNA in blood samples. PLoS Negl Trop Dis 7: e2000. doi: 10.1371/journal.pntd.0002000 23350002
39. Vallejo GA, Guhl F, Schaub GA, (2009) Triatominae-Trypanosoma cruzi/T. rangeli: Vector-parasite interactions. Acta Trop 110: 137–147. doi: 10.1016/j.actatropica.2008.10.001 18992212
40. Angulo VM, Esteban L, Luna KP, (2012) [Attalea butyracea palms adjacent to housing as a source of infestation by Rhodnius prolixus (Hemiptera: Reduviidae)]. Bioméd Rev Inst Nac Salud 32: 277–285.
41. Guhl F, Pinto N, Aguilera G, (2009) Sylvatic triatominae: a new challenge in vector control transmission. Mem Inst Oswaldo Cruz 104 Suppl 1: 71–75. 19753461
42. Yun O, Lima MA, Ellman T, Chambi W, Castillo S, et al. (2009) Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS Negl Trop Dis 3: e488. doi: 10.1371/journal.pntd.0000488 19582142
43. Tsokana CN, Athanasiou LV, Valiakos G, Spyrou V, Manolakou K, Billinis C, Claborn David, Dr. (2014) Molecular Diagnosis of Leishmaniasis, Species Identification and Phylogenetic Analysis. Leishmaniasis—Trends in Epidemiology, Diagnosis and Treatment, (Ed.),
44. Mejía-Jaramillo AM, Fernández GJ, Montilla M, Nicholls RS, Triana-Chávez O, (2012) [Trypanosoma cruzi strains resistant to benznidazole occurring in Colombia]. Bioméd Rev Inst Nac Salud 32: 196–205.
45. Murta SM, Romanha AJ, (1998) In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole. Parasitology 116 (Pt 2): 165–171. 9509026
46. Wilkinson SR, Taylor MC, Horn D, Kelly JM, Cheeseman I, (2008) A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc Natl Acad Sci U S A 105: 5022–5027. doi: 10.1073/pnas.0711014105 18367671
47. Guhl F, Ramírez JD, (2011) Trypanosoma cruzi I diversity: towards the need of genetic subdivision? Acta Trop 119: 1–4. doi: 10.1016/j.actatropica.2011.04.002 21510916